The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tardive Dyskinesia Market Research Report 2025
Synopsis
Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
The global Tardive Dyskinesia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia.
Report Scope
The Tardive Dyskinesia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tardive Dyskinesia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tardive Dyskinesia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Neurocrine Biosciences
Teva Pharmaceuticals Industries
Segment by Type
Dopamine-Depleting Medications
GABA Receptor Agonist Medications
Anticholinergic Medications
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tardive Dyskinesia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
The global Tardive Dyskinesia market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia.
Report Scope
The Tardive Dyskinesia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tardive Dyskinesia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tardive Dyskinesia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Neurocrine Biosciences
Teva Pharmaceuticals Industries
Segment by Type
Dopamine-Depleting Medications
GABA Receptor Agonist Medications
Anticholinergic Medications
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tardive Dyskinesia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dopamine-Depleting Medications
1.2.3 GABA Receptor Agonist Medications
1.2.4 Anticholinergic Medications
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Market Perspective (2019-2030)
2.2 Tardive Dyskinesia Growth Trends by Region
2.2.1 Global Tardive Dyskinesia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tardive Dyskinesia Historic Market Size by Region (2019-2024)
2.2.3 Tardive Dyskinesia Forecasted Market Size by Region (2025-2030)
2.3 Tardive Dyskinesia Market Dynamics
2.3.1 Tardive Dyskinesia Industry Trends
2.3.2 Tardive Dyskinesia Market Drivers
2.3.3 Tardive Dyskinesia Market Challenges
2.3.4 Tardive Dyskinesia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia Players by Revenue
3.1.1 Global Top Tardive Dyskinesia Players by Revenue (2019-2024)
3.1.2 Global Tardive Dyskinesia Revenue Market Share by Players (2019-2024)
3.2 Global Tardive Dyskinesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tardive Dyskinesia Revenue
3.4 Global Tardive Dyskinesia Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Revenue in 2023
3.5 Tardive Dyskinesia Key Players Head office and Area Served
3.6 Key Players Tardive Dyskinesia Product Solution and Service
3.7 Date of Enter into Tardive Dyskinesia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Breakdown Data by Type
4.1 Global Tardive Dyskinesia Historic Market Size by Type (2019-2024)
4.2 Global Tardive Dyskinesia Forecasted Market Size by Type (2025-2030)
5 Tardive Dyskinesia Breakdown Data by Application
5.1 Global Tardive Dyskinesia Historic Market Size by Application (2019-2024)
5.2 Global Tardive Dyskinesia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tardive Dyskinesia Market Size (2019-2030)
6.2 North America Tardive Dyskinesia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tardive Dyskinesia Market Size by Country (2019-2024)
6.4 North America Tardive Dyskinesia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tardive Dyskinesia Market Size (2019-2030)
7.2 Europe Tardive Dyskinesia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tardive Dyskinesia Market Size by Country (2019-2024)
7.4 Europe Tardive Dyskinesia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia Market Size (2019-2030)
8.2 Asia-Pacific Tardive Dyskinesia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tardive Dyskinesia Market Size by Region (2019-2024)
8.4 Asia-Pacific Tardive Dyskinesia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tardive Dyskinesia Market Size (2019-2030)
9.2 Latin America Tardive Dyskinesia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tardive Dyskinesia Market Size by Country (2019-2024)
9.4 Latin America Tardive Dyskinesia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia Market Size (2019-2030)
10.2 Middle East & Africa Tardive Dyskinesia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tardive Dyskinesia Market Size by Country (2019-2024)
10.4 Middle East & Africa Tardive Dyskinesia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Tardive Dyskinesia Introduction
11.1.4 Bausch Health Revenue in Tardive Dyskinesia Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Detail
11.2.2 Neurocrine Biosciences Business Overview
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Introduction
11.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2019-2024)
11.2.5 Neurocrine Biosciences Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Company Detail
11.3.2 Teva Pharmaceuticals Industries Business Overview
11.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Introduction
11.3.4 Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2019-2024)
11.3.5 Teva Pharmaceuticals Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
